← Back
$EBS All transactions

Emergent BioSolutions Inc.

▼ SELL 10b5-1 Plan

$ Value

$34K

Shares

4,000

Price

$8

Filed

Apr 3

Insider

Name

Williams Paul Anthony

Title

SVP, Products Business

CIK

0001961994

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

62,681

Footnotes

All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.34 to $8.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Filing Info

Accession No.

0001961994-26-000013

Form Type

4

Issuer CIK

0001367644

Williams Paul Anthony's History

Date Ticker Type Value
2026-04-01 EBS $34K
2026-03-05 EBS F $79K
2026-03-03 EBS A $0
2026-03-01 EBS F $945
2026-02-06 EBS D $95K
2026-02-06 EBS F $11K
2025-06-08 EBS F $3K

Other Insiders at EBS (90d)

Insider Bought Sold Last
FOWLER JOHN D JR 2026-03-03
LINDAHL RICHARD S
EVP, Chief Financial Officer
2026-03-05
PAPA JOSEPH C
President and CEO
2026-03-05
Glessner Coleen
EVP, Quality & Ethics, and CPL
2026-03-05
Williams Paul Anthony
SVP, Products Business
2026-03-05
Hartzel William
SVP, Bioservices
2026-03-05
Perl Jessica
SVP, General Counsel, Corp Sec
2026-03-05
Lowry Simon C
SVP, R&D, CMO
2026-03-05